DTC
RXDX

Deep Track Capital’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Deep Track Capital’s Portfolio RXDX Stock Details RXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-245,000
Closed -$9.25M – 59
2022
Q1 		$9.25M Buy
+245,000
New +$9.68M 0.59% 39

Other funds holding RXDX

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deep Track Capital's RXDX Position: Q2 2022 in Review

Deep Track Capital sold out of Prometheus Biosciences, Inc. Common Stock (RXDX) in Q2 2022, closing a stake of 245,000 shares — an estimated $9.25M sold.

Deep Track Capital first reported a position in RXDX in Q1 2022 and held it in 1 quarter. The position peaked at $9.25M in Q1 2022. 116 funds tracked by Wall St. Rank hold RXDX as of Q2 2022.

  • Deep Track Capital reported no remaining Prometheus Biosciences, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Deep Track Capital sold 245,000 Prometheus Biosciences, Inc. Common Stock shares in Q2 2022, an estimated $9.25M.
  • Deep Track Capital first reported a position in Prometheus Biosciences, Inc. Common Stock in Q1 2022 and held it in 1 quarter.
  • Deep Track Capital's Prometheus Biosciences, Inc. Common Stock position peaked at $9.25M in Q1 2022.
  • 116 funds tracked by Wall St. Rank held Prometheus Biosciences, Inc. Common Stock as of Q2 2022.

Based on Deep Track Capital's 13F filing for Q2 2022, filed 12 Aug 2022.